Efficacy and Safety of Alirocumab in Individuals with Diabetes Mellitus: Pooled Analyses from Five Placebo-Controlled Phase 3 Studies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-6961
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Efficacy and Safety of Alirocumab in Individuals with Diabetes Mellitus: Pooled Analyses from Five Placebo-Controlled Phase 3 Studies ; volume:9 ; number:3 ; day:19 ; month:5 ; year:2018 ; pages:1317-1334 ; date:6.2018
Diabetes therapy ; 9, Heft 3 (19.5.2018), 1317-1334, 6.2018
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Ginsberg, Henry N.
- Beteiligte Personen und Organisationen
-
Farnier, Michel
Robinson, Jennifer G.
Cannon, Christopher P.
Sattar, Naveed
Baccara-Dinet, Marie T.
Letierce, Alexia
Bujas-Bobanovic, Maja
Louie, Michael J.
Colhoun, Helen M.
SpringerLink (Online service)
- DOI
-
10.1007/s13300-018-0439-8
- URN
-
urn:nbn:de:101:1-2018081511312285669859
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ginsberg, Henry N.
- Farnier, Michel
- Robinson, Jennifer G.
- Cannon, Christopher P.
- Sattar, Naveed
- Baccara-Dinet, Marie T.
- Letierce, Alexia
- Bujas-Bobanovic, Maja
- Louie, Michael J.
- Colhoun, Helen M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Obesity as a Risk Factor for Severe COVID-19: Summary of the Best Evidence and Implications for Health Care
Vitamin D and COVID-19 infection and mortality in UK Biobank
Appetite and its Regulation: Are there Palatable Interventions for Heart Failure?
Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence
Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register
SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
Association of maternal diabetes/glycosuria and pre-pregnancy body mass index with offspring indicators of non-alcoholic fatty liver disease
Metabolic characterization of menopause: cross-sectional and longitudinal evidence
Accuracy of circulating adiponectin for predicting gestational diabetes: a systematic review and meta-analysis
Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study
Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
Metabolic characterization of menopause: cross-sectional and longitudinal evidence
Obesity as a Risk Factor for Severe COVID-19: Summary of the Best Evidence and Implications for Health Care
Vitamin D and COVID-19 infection and mortality in UK Biobank
Appetite and its Regulation: Are there Palatable Interventions for Heart Failure?
Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence
Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register
SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
Association of maternal diabetes/glycosuria and pre-pregnancy body mass index with offspring indicators of non-alcoholic fatty liver disease
Metabolic characterization of menopause: cross-sectional and longitudinal evidence
Accuracy of circulating adiponectin for predicting gestational diabetes: a systematic review and meta-analysis
Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study
Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
Metabolic characterization of menopause: cross-sectional and longitudinal evidence
Obesity as a Risk Factor for Severe COVID-19: Summary of the Best Evidence and Implications for Health Care
Vitamin D and COVID-19 infection and mortality in UK Biobank
Appetite and its Regulation: Are there Palatable Interventions for Heart Failure?
Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence
Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register
SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
Association of maternal diabetes/glycosuria and pre-pregnancy body mass index with offspring indicators of non-alcoholic fatty liver disease
Metabolic characterization of menopause: cross-sectional and longitudinal evidence
Accuracy of circulating adiponectin for predicting gestational diabetes: a systematic review and meta-analysis
Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study
Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)